# A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®

> **NCT01913353** · PHASE3 · COMPLETED · sponsor: **Bavarian Nordic** · enrollment: 440 (actual)

## Conditions studied

- 18-42 Year Old Healthy Vaccinia-naïve Subjects

## Interventions

- **BIOLOGICAL:** MVA BN®
- **BIOLOGICAL:** ACAM2000®

## Key facts

- **NCT ID:** NCT01913353
- **Lead sponsor:** Bavarian Nordic
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2017-03
- **Final completion:** 2017-08
- **Target enrollment:** 440 (ACTUAL)
- **Last updated:** 2019-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01913353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01913353, "A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000®". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01913353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*